Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients
- PMID: 32977128
- PMCID: PMC7491463
- DOI: 10.1016/j.thromres.2020.09.017
Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients
Abstract
Background: Venous thromboembolism (VTE) is a frequent complication in critically ill patients with coronavirus disease 2019 (COVID-19) and is associated with mortality. Early diagnosis and treatment of VTE is warranted.
Objective: To develop a prediction model for VTE in critically ill COVID-19 patients.
Patients and methods: In this retrospective cohort study, 127 adult patients with confirmed COVID-19 infection admitted to the intensive care unit of two teaching hospitals were included. VTE was diagnosed with either ultrasound or computed tomography scan. Univariate receiver operating characteristic (ROC) curves were constructed for Positive End Expiratory Pressure, PaO2/FiO2 ratio, platelet count, international normalized ratio, activated partial thromboplastin time as well as levels of fibrinogen, antithrombin, D-dimer and C-reactive protein (CRP). Multivariate analysis was done using binary linear regression.
Results: Variables associated with VTE in both univariate and multivariate analysis were D-dimer and CRP with an area under the curve (AUC) of 0.64, P = 0.023 and 0.75, P = 0.045, respectively. Variables indicating hypoxemia were not predictive. The ROC curve of D-dimer and CRP combined had an AUC of 0.83, P < 0.05. Categorized values of D-dimer and CRP were used to compute a mean absolute risk for the combination of these variables with a high positive predictive value. The predicted probability of VTE with a D-dimer > 15 in combination with a CRP > 280 was 98%. The negative predictive value of D-dimer was low.
Conclusion: Elevated CRP and D-dimer have a high positive predictive value for VTE in critically ill COVID-19 patients. We developed a prediction table with these biomarkers that can aid clinicians in the timing of imaging in patients with suspected VTE.
Keywords: C-reactive protein; COVID-19; Critical illness; D-dimer; Venous thromboembolism.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
All authors declare no competing interests.
Figures


Similar articles
-
Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019.J Vasc Surg Venous Lymphat Disord. 2021 Jul;9(4):835-844.e4. doi: 10.1016/j.jvsv.2020.11.006. Epub 2020 Nov 12. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 33188961 Free PMC article.
-
COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism.Eur J Vasc Endovasc Surg. 2021 Apr;61(4):628-634. doi: 10.1016/j.ejvs.2020.12.015. Epub 2020 Dec 23. Eur J Vasc Endovasc Surg. 2021. PMID: 33583710 Free PMC article.
-
Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study.J Thromb Haemost. 2021 Apr;19(4):1038-1048. doi: 10.1111/jth.15261. Epub 2021 Feb 24. J Thromb Haemost. 2021. PMID: 33534149 Free PMC article.
-
D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.Vasc Health Risk Manag. 2020 Nov 13;16:455-462. doi: 10.2147/VHRM.S280962. eCollection 2020. Vasc Health Risk Manag. 2020. PMID: 33223833 Free PMC article. Review.
-
Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis.Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029621993573. doi: 10.1177/1076029621993573. Clin Appl Thromb Hemost. 2021. PMID: 33571009 Free PMC article.
Cited by
-
Approach to Thromboprophylaxis for Prevention of Venous Thromboembolism in COVID-19: Global Updates and Clinical Insights from India.Clin Pract. 2022 Sep 23;12(5):766-781. doi: 10.3390/clinpract12050080. Clin Pract. 2022. PMID: 36286066 Free PMC article. Review.
-
The Role of Biomarkers in Hospitalized COVID-19 Patients With Systemic Manifestations.Biomark Insights. 2022 Jun 26;17:11772719221108909. doi: 10.1177/11772719221108909. eCollection 2022. Biomark Insights. 2022. PMID: 35783222 Free PMC article. Review.
-
Diagnostic Accuracy of Liquid Biomarkers in Airway Diseases: Toward Point-of-Care Applications.Front Med (Lausanne). 2022 Jun 6;9:855250. doi: 10.3389/fmed.2022.855250. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35733871 Free PMC article. Review.
-
COVID-19 and venous thromboembolism: A narrative review.Res Pract Thromb Haemost. 2022 Feb 15;6(2):e12666. doi: 10.1002/rth2.12666. eCollection 2022 Feb. Res Pract Thromb Haemost. 2022. PMID: 35224417 Free PMC article. Review.
-
Venous thromboembolism in COVID-19: A systematic review and meta-analysis.Vasc Med. 2021 Aug;26(4):415-425. doi: 10.1177/1358863X21995566. Epub 2021 Apr 4. Vasc Med. 2021. PMID: 33818197 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous